University of Pennsylvania Sues BioNTech Over Unpaid Royalties for COVID-19 Vaccine

BioNTech is facing a breach of contract lawsuit filed by the University of Pennsylvania in the Pennsylvania federal court. The suit alleges that BioNTech has failed to pay royalties on global net sales of its COVID-19 vaccine, Comirnaty. Developed using the university’s critical messenger RNA patents, the vaccine has generated over $75 billion in revenue. For more details, legal professionals can read the comprehensive coverage on Law360.